The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Shin-Ichiro Masunaga

Particle Radiation Oncology Research Center

Research Reactor Institute

Kyoto University

Osaka

Japan

[email]@rri.kyoto-u.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Particle Radiation Oncology Research Center, Research Reactor Institute, Kyoto University, Osaka, Japan. 1999 - 2013

References

  1. Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction. Masunaga, S., Sakurai, Y., Tanaka, H., Hirayama, R., Matsumoto, Y., Uzawa, A., Suzuki, M., Kondo, N., Narabayashi, M., Maruhashi, A., Ono, K. Br. J. Radiol (2013) [Pubmed]
  2. Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations. Masunaga, S., Matsumoto, Y., Kashino, G., Hirayama, R., Liu, Y., Tanaka, H., Sakurai, Y., Suzuki, M., Kinashi, Y., Maruhashi, A., Ono, K. Br. J. Radiol (2010) [Pubmed]
  3. Evaluation of the radiosensitivity of the oxygenated tumor cell fractions in quiescent cell populations within solid tumors. Masunaga, S., Nagasawa, H., Liu, Y., Sakurai, Y., Tanaka, H., Kashino, G., Suzuki, M., Kinashi, Y., Ono, K. Radiat. Res. (2010) [Pubmed]
  4. Influence of manipulating hypoxia in solid tumors on the radiation dose-rate effect in vivo, with reference to that in the quiescent cell population. Masunaga, S., Hirayama, R., Uzawa, A., Kashino, G., Takata, T., Tanaka, H., Suzuki, M., Kinashi, Y., Liu, Y., Koike, S., Ando, K., Ono, K. Jpn. J. Radiol (2010) [Pubmed]
  5. Usefulness of hexamethylenetetramine as an adjuvant to radiation and cisplatin in the treatment of solid tumors: its independency of p53 status. Masunaga, S., Tano, K., Nakamura, J., Watanabe, M., Kashino, G., Takahashi, A., Tanaka, H., Suzuki, M., Ohnishi, K., Kinashi, Y., Liu, Y., Ohnishi, T., Ono, K. J. Radiat. Res. (2010) [Pubmed]
  6. Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells. Masunaga, S., Matsumoto, Y., Hirayama, R., Kashino, G., Tanaka, H., Suzuki, M., Kinashi, Y., Liu, Y., Ando, K., Ono, K. Clin. Exp. Metastasis (2009) [Pubmed]
  7. The effect of post-irradiation tumor oxygenation status on recovery from radiation-induced damage in vivo: with reference to that in quiescent cell populations. Masunaga, S., Hirayama, R., Uzawa, A., Kashino, G., Suzuki, M., Kinashi, Y., Liu, Y., Koike, S., Ando, K., Ono, K. J. Cancer Res. Clin. Oncol. (2009) [Pubmed]
  8. Usefulness of hexamethylenetetramine in combination with chemotherapy using free and pegylated liposomal doxorubicin in vivo, referring to the effect on quiescent cells. Masunaga, S., Kono, K., Nakamura, J., Tano, K., Yoshida, H., Watanabe, M., Kashino, G., Suzuki, M., Kinashi, Y., Liu, Y., Ono, K. Oncol. Rep. (2009) [Pubmed]
  9. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo. Masunaga, S., Tano, K., Watanabe, M., Kashino, G., Suzuki, M., Kinashi, Y., Ono, K., Nakamura, J. Br. J. Radiol (2009) [Pubmed]
  10. Responses of total and quiescent cell populations in solid tumors to carbon ion beam irradiation (290 MeV/u) in vivo. Masunaga, S., Ando, K., Uzawa, A., Hirayama, R., Furusawa, Y., Koike, S., Ono, K. Radiat. Med (2008) [Pubmed]
  11. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams. Masunaga, S., Ando, K., Uzawa, A., Hirayama, R., Furusawa, Y., Koike, S., Sakurai, Y., Nagata, K., Suzuki, M., Kashino, G., Kinashi, Y., Tanaka, H., Maruhashi, A., Ono, K. Int. J. Radiat. Oncol. Biol. Phys. (2008) [Pubmed]
  12. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo. Masunaga, S., Ando, K., Uzawa, A., Hirayama, R., Furusawa, Y., Koike, S., Ono, K. Acta. Oncol (2008) [Pubmed]
  13. The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose-rate irradiation with gamma-rays. Masunaga, S., Nagasawa, H., Uto, Y., Hori, H., Nagata, K., Suzuki, M., Kashino, G., Kinashi, Y., Ono, K. Int. J. Hyperthermia (2007) [Pubmed]
  14. Dependency of repair of radiation-induced damage on p53 status and efficient inhibition of the repair with wortmannin treatment in vivo, with reference to the effect on intratumor quiescent cell population. Masunaga, S., Takahashi, A., Ohnishi, K., Nagata, K., Suzuki, M., Kashino, G., Kinashi, Y., Ohnishi, T., Ono, K. Oncol. Rep. (2007) [Pubmed]
  15. Inhibition of repair of radiation-induced damage by mild temperature hyperthermia, referring to the effect on quiescent cell populations. Masunaga, S., Nagata, K., Suzuki, M., Kashino, G., Kinashi, Y., Ono, K. Radiat. Med (2007) [Pubmed]
  16. Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells. Masunaga, S., Nagasawa, H., Nagata, K., Suzuki, M., Uto, Y., Hori, H., Kinashi, Y., Ono, K. J. Cancer Res. Clin. Oncol. (2007) [Pubmed]
  17. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga, S., Uto, Y., Nagasawa, H., Hori, H., Nagata, K., Suzuki, M., Kinashi, Y., Ono, K. Anticancer Res. (2006) [Pubmed]
  18. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy. Masunaga, S., Nagasawa, H., Sakurai, Y., Uto, Y., Hori, H., Nagata, K., Suzuki, M., Maruhashi, A., Kinashi, Y., Ono, K. Int. J. Hyperthermia (2006) [Pubmed]
  19. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons. Masunaga, S., Sakurai, Y., Nagata, K., Suzuki, M., Maruhashi, A., Kinashi, Y., Nagasawa, H., Uto, Y., Hori, H., Ono, K. Br. J. Radiol (2006) [Pubmed]
  20. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy. Masunaga, S., Kasaoka, S., Maruyama, K., Nigg, D., Sakurai, Y., Nagata, K., Suzuki, M., Kinashi, Y., Maruhashi, A., Ono, K. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  21. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells. Masunaga, S., Nagasawa, H., Uto, Y., Hori, H., Ohnishi, K., Takahashi, A., Ohnishi, T., Suzuki, M., Nagata, K., Kinashi, Y., Ono, K. Oncol. Rep. (2005) [Pubmed]
  22. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Masunaga, S., Nagasawa, H., Uto, Y., Hori, H., Suzuki, M., Nagata, K., Kinashi, Y., Ono, K. Int. J. Hyperthermia (2005) [Pubmed]
  23. The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy. Masunaga, S., Nagasawa, H., Hiraoka, M., Sakurai, Y., Uto, Y., Hori, H., Nagata, K., Suzuki, M., Maruhashi, A., Kinashi, Y., Ono, K. Appl. Radiat. Isot (2004) [Pubmed]
  24. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations. Masunaga, S., Takahashi, A., Ohnishi, K., Ohnishi, T., Nagata, K., Suzuki, M., Kinashi, Y., Ono, K. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  25. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy. Masunaga, S., Sakurai, Y., Suzuki, M., Nagata, K., Maruhashi, A., Kinash, Y., Ono, K. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  26. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy. Masunaga, S., Nagasawa, H., Hiraoka, M., Sakurai, Y., Uto, Y., Hori, H., Nagata, K., Suzuki, M., Maruhashi, A., Kinashi, Y., Ono, K. Anticancer Res. (2004) [Pubmed]
  27. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers. Masunaga, S., Ono, K., Kirihata, M., Takagaki, M., Sakurai, Y., Kinashi, Y., Kobayashi, T., Suzuki, M., Nagata, K., Nagasawa, H., Uto, Y., Hori, H. J. Cancer Res. Clin. Oncol. (2003) [Pubmed]
  28. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status. Masunaga, S., Ono, K., Takahashi, A., Ohnishi, K., Ohnishi, T., Suzuki, M., Nagata, K., Kinashi, Y., Nagasawa, H., Uto, Y., Hori, H. Cancer Sci. (2003) [Pubmed]
  29. Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells. Masunaga, S., Ono, K., Takahashi, A., Ohnishi, T., Kinashi, Y., Takagaki, M. Eur. J. Cancer (2002) [Pubmed]
  30. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. Masunaga, S., Ono, K. J. Radiat. Res. (2002) [Pubmed]
  31. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells. Masunaga, S., Ono, K., Takahashi, A., Sakurai, Y., Ohnishi, K., Kobayashi, T., Kinashi, Y., Takagaki, M., Ohnishi, T. Jpn. J. Cancer Res. (2002) [Pubmed]
  32. Radiobiologic significance of apoptosis and micronucleation in quiescent cells within solid tumors following gamma-ray irradiation. Masunaga, S., Ono, K., Suzuki, M., Kinashi, Y., Takagaki, M. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
  33. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells. Masunaga, S.I., Ono, K., Suzuki, M., Nishimura, Y., Kinashi, Y., Takagaki, M., Hori, H., Nagasawa, H., Uto, Y., Tsuchiya, I., Sadahiro, S., Murayama, C. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
  34. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells. Masunaga, S.I., Ono, K., Kirihata, M., Takagaki, M., Sakurai, Y., Kinashi, Y., Kobayashi, T., Nagasawa, H., Uto, Y., Hori, H. Jpn. J. Cancer Res. (2001) [Pubmed]
  35. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors. Masunaga, S., Ono, K., Sakurai, Y., Takagaki, M., Kobayashi, T., Kinashi, Y., Suzuki, M. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
  36. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound. Masunaga, S., Ono, K., Suzuki, M., Sakurai, Y., Kobayashi, T., Takagaki, M., Kinashi, Y., Akaboshi, M. Int. J. Radiat. Oncol. Biol. Phys. (2000) [Pubmed]
  37. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells. Masunaga, S.I., Ono, K., Suzuki, M., Kinashi, Y., Takagaki, M., Hori, H., Kasai, S., Nagasawa, H., Uto, Y. Jpn. J. Cancer Res. (2000) [Pubmed]
  38. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells. Masunaga, S., Ono, K., Nishimura, Y., Kanamori, S., Saga, T., Suzuki, M., Kinashi, Y., Takagaki, M., Kasai, S., Nagasawa, H., Uto, Y., Hori, H. Int. J. Radiat. Oncol. Biol. Phys. (2000) [Pubmed]
  39. Changes in the sensitivity of intratumor cells during fractionated tirapazamine administration. Masunaga, S., Ono, K., Suzuki, M., Kinashi, Y., Takagaki, M., Kasai, S., Nagasawa, H., Uto, Y., Hori, H. Jpn. J. Cancer Res. (2000) [Pubmed]
  40. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction. Masunaga, S., Ono, K., Suzuki, M., Sakurai, Y., Takagaki, M., Kobayashi, T., Kinashi, Y., Akaboshi, M. J. Cancer Res. Clin. Oncol. (1999) [Pubmed]
 
WikiGenes - Universities